Publications by authors named "Shakeel Modak"

Claim this Profile
R
Rapid COJEC without myeloablative therapy for high-risk neuroblastoma.
Brian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, Kim Kramer, Shakeel Modak

Int J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single Institutional Experience Using Romiplostim to Treat Therapy-Related Thrombocytopenia in Pediatric Solid Tumor Patients.
Melanie D Degliuomini, Katherine Armstrong, Michael Curry, Audrey Mauguen, Shakeel Modak

Pediatr Blood Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trial.
Brian H Kushner, Shakeel Modak, Audrey Mauguen, Ellen M Basu, Stephen S Roberts

J Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lesion Analysis of F-Metafluorobenzylguanidine PET Imaging in Neuroblastoma.
Neeta Pandit-Taskar, Ellen Basu, Ali Pirasteh, Gerald Behr, Audrey Mauguen, Shakeel Modak

J Nucl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacological and clinical profile of Naxitamab for the treatment of high-risk neuroblastoma.
Wei Wei, Shakeel I Modak

Expert Rev Clin Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Control With Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results From a Prospective Clinical Trial.
Christopher B Jackson, Dana L Casey, Brian H Kushner, Shakeel Modak, Zhigang Zhang

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Steven G DuBois, Lucas Moreno, John Anderson, Shahab Asgharzadeh, Ro Bagatell, Shakeel Modak

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Toxicity Associated With Concurrent Lorlatinib and Anti-GD2 Monoclonal Antibody Therapy in Patients With Neuroblastoma.
Wei Wei, Maggie Eidson Fader, Brian H Kushner, Fiorella Iglesias Cardenas, Kim Kramer, Shakeel Modak

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gunes Gundem, Max F Levine, Stephen S Roberts, Irene Y Cheung, Juan S Medina-Martínez, Shakeel Modak

Nat Genet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Promoter Mutations in Neuroblastoma.
Natasha Persaud, Gunes Gundem, Brian H Kushner, Marc Ladanyi, Neerav Shukla, Shakeel Modak

JCO Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission.
Brian H Kushner, Shakeel Modak, Audrey Mauguen, Ellen M Basu, Kim Kramer

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety observations in neuroblastoma patients undergoing 18 F- m FBG PET.
Neeta Pandit-Taskar, Ellen Basu, Eloisa Balquin, P David Mozley, Arnold F Jacobson, Shakeel Modak

Nucl Med Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Detection.
Subhanik Purkayastha, Hrithwik Shalu, David Gutman, Andrei Holodny, Shakeel Modak

J Imaging Inform Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab for Treatment of Anti-GD2 Antibody-related Urticaria.
Rachel Glincher, Angela Lentini-Rivera, Latisha Andre Jones, Linda D'Andrea, Christina Durney, Shakeel Modak

J Pediatr Hematol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian function in female survivors of high-risk neuroblastoma.
Lauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, Chaya S Moskowitz, Kimberly Bogardus, Shakeel Modak

Pediatr Blood Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience.
Brianna Conte, Dana L Casey, Kathryn R Tringale, Joshua Honeyman, Nicole J C Narayan, Shakeel Modak

Pract Radiat Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Prime-Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.
Irene Y Cheung, Audrey Mauguen, Shakeel Modak, Ellen M Basu, Yi Feng

Vaccines (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma.
Jaume Mora, Shakeel Modak, Joyce Kinsey, Carolyn E Ragsdale, Hillard M Lazarus

Int J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub

J Immunother Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage 4N neuroblastoma before and during the era of anti-G immunotherapy.
Brian H Kushner, Michael P LaQuaglia, Fiorella Iglesias Cardenas, Ellen M Basu, Justin T Gerstle, Shakeel Modak

Int J Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells.
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub

Res Sq· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations.
Behtash G Nezami, Shakeel Modak, Fiorella Iglesias Cardenas, Judy Sarungbam, Sahussapont J Sirintrapun

Pediatr Blood Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults.
Jessica Stiefel, Brian H Kushner, Stephen S Roberts, Fiorella Iglesias-Cardenas, Kim Kramer, Shakeel Modak

JCO Precis Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunoscintigraphy and Pretreatment Dosimetry of I-Omburtamab for Planning Treatment of Leptomeningeal Disease.
Neeta Pandit-Taskar, Milan Grkovski, Pat B Zanzonico, Keith S Pentlow, Shakeel Modak

J Nucl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gunes Gundem, Max F Levine, Stephen S Roberts, Irene Y Cheung, Juan S Medina-Martínez, Shakeel Modak

Nat Genet· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis